Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101.

Qazi AM, Gruzdyn O, Semaan A, Seward S, Chamala S, Dhulipala V, Sethi S, Ali-Fehmi R, Philip PA, Bouwman DL, Weaver DW, Gruber SA, Batchu RB.

Surgery. 2012 Oct;152(4):704-11; discussion 711-3. doi: 10.1016/j.surg.2012.07.020. Epub 2012 Sep 1.

PMID:
22943841
2.

MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis.

Kadera BE, Li L, Toste PA, Wu N, Adams C, Dawson DW, Donahue TR.

PLoS One. 2013 Aug 22;8(8):e71978. doi: 10.1371/journal.pone.0071978. eCollection 2013.

3.

Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.

Li CH, To KF, Tong JH, Xiao Z, Xia T, Lai PB, Chow SC, Zhu YX, Chan SL, Marquez VE, Chen Y.

Gastroenterology. 2013 May;144(5):1086-1097.e9. doi: 10.1053/j.gastro.2013.01.058. Epub 2013 Feb 7.

PMID:
23395645
4.

MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.

du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.

Clin Chem. 2010 Apr;56(4):603-12. doi: 10.1373/clinchem.2009.137364. Epub 2010 Jan 21.

5.

Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.

Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.

Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.

PMID:
19475450
6.

Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.

Xu H, Inagaki Y, Seyama Y, Du G, Wang F, Kokudo N, Tang W.

Oncol Rep. 2011 Aug;26(2):371-6. doi: 10.3892/or.2011.1315. Epub 2011 May 23.

PMID:
21617869
7.

Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.

Zhao C, Zhang J, Zhang S, Yu D, Chen Y, Liu Q, Shi M, Ni C, Zhu M.

Oncol Rep. 2013 Jul;30(1):276-84. doi: 10.3892/or.2013.2420. Epub 2013 Apr 23.

PMID:
23612862
8.

MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.

Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, Nagai E, Oda Y, Tanaka M.

Surgery. 2011 Nov;150(5):916-22. doi: 10.1016/j.surg.2011.06.017.

PMID:
22018284
9.

Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.

Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y, Liu QH, Shi M, Ni CR, Zhu MH.

Oncol Rep. 2014 Mar;31(3):1157-64. doi: 10.3892/or.2013.2960. Epub 2013 Dec 31.

PMID:
24398877
10.

EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarcinoma.

Batchu RB, Qazi AM, Gruzdyn OV, Semaan A, Seward SM, Chamala S, Dhulipala VB, Bouwman DL, Weaver DW, Gruber SA.

Surgery. 2013 Oct;154(4):739-46; discussion 746-7. doi: 10.1016/j.surg.2013.06.041.

PMID:
24074410
11.

Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.

Wang P, Chen L, Zhang J, Chen H, Fan J, Wang K, Luo J, Chen Z, Meng Z, Liu L.

Oncogene. 2014 Jan 23;33(4):514-24. doi: 10.1038/onc.2012.598. Epub 2013 Jan 21.

PMID:
23334332
12.

miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2.

Cai B, An Y, Lv N, Chen J, Tu M, Sun J, Wu P, Wei J, Jiang K, Miao Y.

Oncol Rep. 2013 May;29(5):1769-76. doi: 10.3892/or.2013.2297. Epub 2013 Feb 21.

PMID:
23440261
13.

MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.

He D, Miao H, Xu Y, Xiong L, Wang Y, Xiang H, Zhang H, Zhang Z.

PLoS One. 2014 Nov 20;9(11):e112930. doi: 10.1371/journal.pone.0112930. eCollection 2014.

14.

EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.

Li CH, Xiao Z, Tong JH, To KF, Fang X, Cheng AS, Chen Y.

Int J Cancer. 2017 Jan 1;140(1):120-129. doi: 10.1002/ijc.30414. Epub 2016 Sep 19.

PMID:
27594424
15.
16.

MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.

Sun Y, Zhang T, Wang C, Jin X, Jia C, Yu S, Chen J.

PLoS One. 2015 Apr 9;10(4):e0119783. doi: 10.1371/journal.pone.0119783. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128257.

17.

miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.

Gao W, Gu Y, Li Z, Cai H, Peng Q, Tu M, Kondo Y, Shinjo K, Zhu Y, Zhang J, Sekido Y, Han B, Qian Z, Miao Y.

Oncogene. 2015 Mar 26;34(13):1629-40. doi: 10.1038/onc.2014.101. Epub 2014 Apr 28.

PMID:
24769899
18.

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.

Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.

Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.

19.

The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.

Deng J, He M, Chen L, Chen C, Zheng J, Cai Z.

PLoS One. 2013 Oct 8;8(10):e76450. doi: 10.1371/journal.pone.0076450. eCollection 2013.

20.

Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.

Yamahatsu K, Matsuda Y, Ishiwata T, Uchida E, Naito Z.

Int J Oncol. 2012 May;40(5):1345-57. doi: 10.3892/ijo.2012.1333. Epub 2012 Jan 13.

PMID:
22246533

Supplemental Content

Support Center